Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 245

1.

How to measure factor VII and factor VII activation.

Osterud B.

Haemostasis. 1983;13(3):161-8. Review.

PMID:
6350121
2.

Activation of human factor VII during clotting in vitro.

Rao LV, Bajaj SP, Rapaport SI.

Blood. 1985 Jan;65(1):218-26.

3.
4.

Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study.

Miller GJ, Stirling Y, Esnouf MP, Heinrich J, van de Loo J, Kienast J, Wu KK, Morrissey JH, Meade TW, Martin JC, et al.

Thromb Haemost. 1994 Jan;71(1):38-48.

PMID:
8165645
5.

Evaluation of a coagulation assay determining the activity state of factor VII in plasma.

van Deijk WA, van Dam-Mieras MC, Muller AD, Hemker HC.

Haemostasis. 1983;13(3):192-7.

PMID:
6604003
6.

Factor VII activation and oral contraceptives.

Plu-Bureau G, Scarabin PY, Bara L, Malmejac A, Guize L, Samama M.

Thromb Res. 1993 May 1;70(3):275-80.

PMID:
8327993
7.

Comparison of coagulant activity of factor VII and activated factor VII activity assays when used for determination of recombinant activated factor VII levels in plasma.

Scharling B, Nielsen GG, Klitgaard T, Skovsted TA, Møss J, Segel S, Larsen LF.

Blood Coagul Fibrinolysis. 2007 Oct;18(7):677-84.

PMID:
17890956
8.

Age-related changes in factor VII activation in healthy women.

Scarabin PY, Van Dreden P, Bonithon-Kop C, Orssaud G, Bara L, Conard J, Samama M.

Clin Sci (Lond). 1988 Oct;75(4):341-3.

PMID:
3264227
9.

Regulation of the initiation of coagulation by factor VII.

Nemerson Y.

Haemostasis. 1983;13(3):150-5. Review.

PMID:
6350119
10.
11.
12.

Hereditary factor VII deficiency: heterogeneity defined by combined functional and immunochemical analysis.

Triplett DA, Brandt JT, Batard MA, Dixon JL, Fair DS.

Blood. 1985 Dec;66(6):1284-7.

13.

Plasma factor VII and its relation to adipose tissue fatty acids and other atherogenic risk factors in healthy men.

Cigolini M, Targher G, Seidell JC, Schiavon R, Tonoli M, Muggeo M, De Sandre G.

Eur J Clin Invest. 1996 Mar;26(3):247-53.

PMID:
8904355
14.

The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.

Kario K, Matsuo T, Asada R, Sakata T, Kato H, Miyata T.

Thromb Haemost. 1995 Mar;73(3):429-34.

PMID:
7667824
15.

The role of factor VII in the intrinsic pathway: a brief review.

Prydz H.

Haemostasis. 1983;13(3):156-60. Review.

PMID:
6350120
16.

The activity state of factor VII in plasma: two pathways for the cold promoted activation of factor VII.

Muller AD, van Deijk WA, Devilée PP, van Dam-Mieras MC, Hemker HC.

Br J Haematol. 1986 Feb;62(2):367-77.

PMID:
3484966
17.
18.

Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.

Chang YJ, Hamaguchi N, Chang SC, Ruf W, Shen MC, Lin SW.

Biochemistry. 1999 Aug 24;38(34):10940-8.

PMID:
10460149
20.

An evaluation of chromogenic substrates in the control of oral anticoagulant therapy.

Latallo ZS, Thomson JM, Poller L.

Br J Haematol. 1981 Feb;47(2):307-18.

PMID:
7470395
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk